Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 6
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Correction to: The early therapeutic response at 2 weeks is a crucial predictor of proton pump inhibitor-refractory gastroesophageal reflux disease.
Ogawa M, Arihiro S, Matsuhashi N, Joh T, Higuchi K, Iwakiri K, Kamiya T, Manabe N, Isshi K, Nakada T, Hokari A, Saruta M, Oshio A, Haruma K, Nakada K. Ogawa M, et al. Among authors: nakada t. Esophagus. 2021 Jul;18(3):711-712. doi: 10.1007/s10388-021-00837-x. Esophagus. 2021. PMID: 33830388 No abstract available.
Comparison of the effects of individual symptoms of gastroesophageal reflux disease co-existing functional dyspepsia on patients' daily lives: A prospective, observational study.
Nakada T, Isshi K, Matsuhashi N, Iwakiri K, Kamiya T, Manabe N, Higuchi K, Joh T, Oshio A, Ogawa M, Hokari A, Saruta M, Haruma K, Nakada K. Nakada T, et al. JGH Open. 2022 Nov 5;6(12):886-893. doi: 10.1002/jgh3.12837. eCollection 2022 Dec. JGH Open. 2022. PMID: 36514504 Free PMC article.
Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report.
Arai Y, Ogawa M, Yamane F, Sumiyoshi N, Arimoto R, Ando Y, Endo D, Nakada T, Sugawara I, Yokoyama H, Shimoyama K, Inomata H, Kawahara Y, Kato M, Arihiro S, Hokari A, Saruta M. Arai Y, et al. Among authors: nakada t. Clin J Gastroenterol. 2020 Dec;13(6):1200-1204. doi: 10.1007/s12328-020-01216-2. Epub 2020 Sep 3. Clin J Gastroenterol. 2020. PMID: 32880812
Correction to: Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report.
Arai Y, Ogawa M, Yamane F, Sumiyoshi N, Arimoto R, Ando Y, Endo D, Nakada T, Sugawara I, Yokoyama H, Shimoyama K, Inomata H, Kawahara Y, Kato M, Arihiro S, Hokari A, Saruta M. Arai Y, et al. Among authors: nakada t. Clin J Gastroenterol. 2021 Apr;14(2):696. doi: 10.1007/s12328-020-01246-w. Clin J Gastroenterol. 2021. PMID: 32978712 No abstract available.